Atea Pharmaceuticals, Inc.
For the period ended Jun 30, 2025. Filed Aug 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 7, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
The following table summarizes repurchases of our common stock during the three months ended June 30, 2025:
| Period | Total Number of Shares Purchased | Average Price Paid per Share (1) | Total Number of Shares Repurchased as Part of a Publicly Announced Plan or Program | Maximum Value of Shares that May Yet be Repurchased Under the Plan or Program (1) |
|---|---|---|---|---|
| April 1 - 30 | 299,400 | $2.86 | 299,400 | $24,143,716 |
| May 1 - 31 | 2,663,517 | $2.85 | 2,663,517 | $16,562,331 |
| June 1 - 30 | 1,656,680 | $3.30 | 1,656,680 | $11,091,523 |
| Total | 4,619,597 | $3.01 | 4,619,597 | |
| (1) Excludes transaction cost and excise taxes | ||||
On April 17, 2025, we publicly announced that our Board of Directors approved a stock repurchase program (the “Share Repurchase Program”), authorizing the repurchase of up to $25.0 million of Company common stock. The Share Repurchase Program has no expiration date. Repurchases may occur from time to time in the open market, including through Rule 10b5-1 plans, or through privately negotiated transactions. The actual timing, price, and number of shares remaining to be repurchased under the Share Repurchase Program will depend on a number of factors, including constraints specified in any trading plan that has been adopted by the Company in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, price, and general business and market conditions. The repurchases made in the three months ended June 30, 2025 were made in accordance with Rule 10b-18 under the Exchange Act and were funded using cash on hand. The Share Repurchase Program does not obligate us to acquire any specific number of shares in any period, and may be expanded, extended, modified or discontinued at any time. For information regarding our Share Repurchase Program, see Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations. – Financial Resources.
Recent Sales of Unregistered Securities
None.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.